
The FDA cleared Access MeMed BV, a host-response blood test that helps distinguish bacterial from viral infections in adults and children in as little as 15 minutes.
Few primary care clinicians in the US are likely to face this rare but deadly disease in daily practice. But if one of your patients had symptoms or was infected, would you make the decision to help treat?
Would you be willing to treat a patient with Ebola?
